Cerity Partners LLC

Position in VCEL — Vericel Corp

CIK 1566475 NEW YORK, NY

Position in VCEL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,989,281

+$1,158,295 QoQ

Shares Held

67,190

+18.1% QoQ

Ownership

0.131%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#87

of 317 holders

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 22% Shared 67% None 11%

Healthcare · as of Jun 30, 2026

Cerity Partners LLC holds $426,228,183 across 139 Biotechnology names. VCEL ranks #15 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	255,874	$127,100,291
2	CORT	Corcept Therapeutics Inc	797,119	$69,309,495
3	HALO	Halozyme Therapeutics, Inc.	343,589	$26,892,710
4	REGN	Regeneron Pharmaceuticals, Inc.	39,274	$24,488,909
5	INCY	Incyte Corp	205,071	$23,246,847
6	EXEL	Exelixis, Inc.	377,130	$20,519,642
7	JAZZ	Jazz Pharmaceuticals plc	53,534	$12,900,087
8	RPRX	Royalty Pharma plc	180,772	$10,135,884

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,989,281	67,190	+18.1%	Shares	Other	2026-08-14
2026-03-31	$1,830,986	56,916	-2.8%	Shares	Sole	2026-05-15
2025-12-31	$2,108,493	58,553	+9.1%	Shares	Sole	2026-02-11
2025-09-30	$1,689,466	53,685	-10.4%	Shares	Sole	2025-10-22
2025-06-30	$2,549,596	59,920	-8.4%	Shares	Defined	2025-08-13
2025-03-31	$2,917,434	65,384	+10.1%	Shares	Sole	2025-04-30
2024-12-31	$3,261,434	59,396	-12.1%	Shares	Other	2025-02-13
2024-09-30	$2,855,593	67,588	+123.2%	Shares	Sole	2024-11-12
2024-06-30	$1,389,108	30,277	-11.7%	Shares	Sole	2024-08-13
2024-03-31	$1,783,973	34,294	+1239.6%	Shares	Defined	2024-05-14
2023-03-31	$75,059	2,560	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.